Revolutionary HT microscopy opens new era for label-free 3D imaging of living cells

Tomocube’s revolutionary holotomography technique delivers 3D structural and chemical information quickly and simply without any labeling or pre-preparation

Quantitative characterization of SH-SY5Y cells in the presence of MPP+. Red, Apoptotic cells; Green, Dividing cells; Blue, Normal cells.

A spin-out company from the renowned Korea Advanced Institute of Science and Technology in Daejeon has been established to commercialize the revolutionary Holotomography (HT) microscopy developed there by Professor Yong Keun (Paul) Park.

Tomocube, the new company sees Park serving as Chief Technology Officer while co-founder Kihyun (Kenny) Hong is CEO. They are joined as Chief Marketing Officer by Aubrey Lambert who spent almost 30 years with Carl Zeiss Microscopy in national and international positions.

Tomocube’s novel optical technology will be of interest to all life scientists, especially those using live cells or thin tissues in their work.

HT microscopy is an optical technique analogous to X-ray computed tomography (CT), which exploits laser holography and computed tomography to quantitatively and non-invasively investigate biological cells and thin tissues, simply and rapidly.

The technique reconstructs the 3D refractive index (RI) distributions of biological material to resolve highly detailed structural and chemical information, including dry mass, morphology, and dynamics of the cellular membrane.

Unlike traditional optical microscopes that only provide users with a two-dimensional view of their samples, Tomocube’s HT microscopy offers high-resolution 3D images of living cells. However, it does this without the need for labeling or extensive pre-preparation, in stark contrast with expensive atomic force, electron and laser-scanning light microscopes that have been used for detailed 3D studies until now.

According to Aubrey Lambert:

Tomocube is dedicated to delivering products that can enhance biological and medical research and the eventual treatment of diseases. Our platform enables researchers to capture and measure nanoscale, real-time, dynamic images of individual living cells without the need for sample preparation. It also permits the retrieval of unique cell properties, including cell volume, shapes of sub-cellular organelles, cytoplasmic density, surface area, and deformability. Our hope is that in allowing the easy and rapid 3D observation of biological cells, HT microscopy will help more scientists quantitatively study cell pathophysiology.”

Source: http://www.tomocube.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tomocube Inc.. (2019, February 26). Revolutionary HT microscopy opens new era for label-free 3D imaging of living cells. News-Medical. Retrieved on May 04, 2024 from https://www.news-medical.net/news/20180821/Revolutionary-HT-microscopy-opens-new-era-for-label-free-3D-imaging-of-living-cells.aspx.

  • MLA

    Tomocube Inc.. "Revolutionary HT microscopy opens new era for label-free 3D imaging of living cells". News-Medical. 04 May 2024. <https://www.news-medical.net/news/20180821/Revolutionary-HT-microscopy-opens-new-era-for-label-free-3D-imaging-of-living-cells.aspx>.

  • Chicago

    Tomocube Inc.. "Revolutionary HT microscopy opens new era for label-free 3D imaging of living cells". News-Medical. https://www.news-medical.net/news/20180821/Revolutionary-HT-microscopy-opens-new-era-for-label-free-3D-imaging-of-living-cells.aspx. (accessed May 04, 2024).

  • Harvard

    Tomocube Inc.. 2019. Revolutionary HT microscopy opens new era for label-free 3D imaging of living cells. News-Medical, viewed 04 May 2024, https://www.news-medical.net/news/20180821/Revolutionary-HT-microscopy-opens-new-era-for-label-free-3D-imaging-of-living-cells.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research could lead to 'breakthrough' for myelodysplastic syndrome